Neurological Disorders Pharmacotherapy for Epilepsy & Parkinsons Disease
Tracking # 20-1395873
Course overview
1. Describe the mechanisms of action of antiseizure medications, including sodium and calcium channel blockers and GABA modulators. 2. Compare the clinical benefits, risks, and drug interaction profiles of older versus newer antiseizure medications. 3. Identify appropriate indications for the use of specific antiseizure medications based on seizure type and patient profile. 4. Assess and manage adverse effects and safety concerns associated with antiseizure pharmacotherapy, including considerations for special populations. 5. Formulate evidence-based treatment plans for both acute and long-term seizure control, and evaluate patient responses to optimize care outcomes.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Registered Nurse
District of Columbia Board of Nursing
Registered Nurse
Florida Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Kansas State Board of Nursing
Registered Nurse
Michigan Board of Nursing
Registered Nurse
Mississippi Board of Nursing
Registered Nurse
New Hampshire Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
New Mexico Board of Nursing
Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
Tennessee Board of Nursing
Advanced Practice Registered Nurse
Registered Nurse
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Wyoming Board of Nursing
Registered Nurse
Disclosure statements
eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content.
All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.